These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20856238)

  • 1. MDR1-P-glycoprotein (ABCB1)-mediated disposition of amyloid-β peptides: implications for the pathogenesis and therapy of Alzheimer's disease.
    Jedlitschky G; Vogelgesang S; Kroemer HK
    Clin Pharmacol Ther; 2010 Oct; 88(4):441-3. PubMed ID: 20856238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
    Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.
    Kuhnke D; Jedlitschky G; Grube M; Krohn M; Jucker M; Mosyagin I; Cascorbi I; Walker LC; Kroemer HK; Warzok RW; Vogelgesang S
    Brain Pathol; 2007 Oct; 17(4):347-53. PubMed ID: 17610523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta.
    Tai LM; Loughlin AJ; Male DK; Romero IA
    J Cereb Blood Flow Metab; 2009 Jun; 29(6):1079-83. PubMed ID: 19367293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
    Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
    Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ABC transporters in the pathogenesis of Alzheimer's disease.
    Abuznait AH; Kaddoumi A
    ACS Chem Neurosci; 2012 Nov; 3(11):820-31. PubMed ID: 23181169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?
    Chai AB; Leung GKF; Callaghan R; Gelissen IC
    FEBS J; 2020 Feb; 287(4):612-625. PubMed ID: 31750987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease.
    Sita G; Hrelia P; Tarozzi A; Morroni F
    Oxid Med Cell Longev; 2017; 2017():7905486. PubMed ID: 29317984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease.
    Cascorbi I; Flüh C; Remmler C; Haenisch S; Faltraco F; Grumbt M; Peters M; Brenn A; Thal DR; Warzok RW; Vogelgesang S
    Pharmacogenomics; 2013 Apr; 14(5):485-94. PubMed ID: 23556446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy.
    Carrano A; Snkhchyan H; Kooij G; van der Pol S; van Horssen J; Veerhuis R; Hoozemans J; Rozemuller A; de Vries HE
    Neurobiol Aging; 2014 Mar; 35(3):565-75. PubMed ID: 24138987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drugs modulate ATP-Binding cassette transporter-mediated transport of amyloid beta
    Shubbar MH; Penny JI
    Eur J Pharmacol; 2020 May; 874():173009. PubMed ID: 32061744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models.
    Chai AB; Hartz AMS; Gao X; Yang A; Callaghan R; Gelissen IC
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells.
    Shubbar MH; Penny JI
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2314-2322. PubMed ID: 30048740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
    Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
    Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid β -Peptide from the Brain.
    Wang W; Bodles-Brakhop AM; Barger SW
    Curr Alzheimer Res; 2016; 13(6):615-20. PubMed ID: 26971931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the Impact of Lithium Chloride on the Expression of P-Glycoprotein at the Blood-Brain Barrier.
    Newman SA; Pan Y; Short JL; Nicolazzo JA
    J Pharm Sci; 2017 Sep; 106(9):2625-2631. PubMed ID: 28093288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling.
    Park R; Kook SY; Park JC; Mook-Jung I
    Cell Death Dis; 2014 Jun; 5(6):e1299. PubMed ID: 24967961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.
    Hartz AM; Miller DS; Bauer B
    Mol Pharmacol; 2010 May; 77(5):715-23. PubMed ID: 20101004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.